{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:09:18Z","timestamp":1761127758227},"reference-count":14,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The activity of MK-0826, a new carbapenem, against 309\n            <jats:italic>Bacteroides fragilis<\/jats:italic>\n            group strains was investigated and compared with that of 11 other \u03b2-lactam and 5 non-\u03b2-lactam agents. MK-0826 showed excellent activity (MICs ranged from \u22640.06 to 4 \u03bcg\/ml). The new carbapenem may be useful in the treatment of mixed anaerobic infections involving\n            <jats:italic>B. fragilis<\/jats:italic>\n            group strains.\n          <\/jats:p>","DOI":"10.1128\/aac.45.8.2372-2374.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"2372-2374","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["In Vitro Activities of MK-0826 and 16 Other Antimicrobials against\n            <i>Bacteroides fragilis<\/i>\n            Group Strains"],"prefix":"10.1128","volume":"45","author":[{"given":"Carmen","family":"Betriu","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Clinical Microbiology, Hospital Cl\u0131\u0301nico San Carlos, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sa\u0301nchez","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Clinical Microbiology, Hospital Cl\u0131\u0301nico San Carlos, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u0131\u0301a Luisa","family":"Palau","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Clinical Microbiology, Hospital Cl\u0131\u0301nico San Carlos, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u0131\u0301a","family":"Go\u0301mez","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Clinical Microbiology, Hospital Cl\u0131\u0301nico San Carlos, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Picazo","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Clinical Microbiology, Hospital Cl\u0131\u0301nico San Carlos, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0732-8893(94)90026-4","article-title":"A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamicins, penicillins, clindamycin, and metronidazole in the United States.","volume":"18","author":"Aldridge K. E.","year":"1994","unstructured":"Aldridge K. E. Gelfand M. Reller L. B. Ayers L. W. Pierson C. L. Schoenknecht F. Tilton R. C. Wilkins J. Henderberg A. Schiro D. D. Johnson M. Janney A. Sanders C. V. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamicins, penicillins, clindamycin, and metronidazole in the United States. Diagn. Microbiol. Infect. Dis. 18 1994 235 241","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1238-1243.2001"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1093\/clinids\/16.Supplement_4.S382","article-title":"Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.","volume":"16","author":"Bandoh K.","year":"1993","unstructured":"Bandoh K. Ueno K. Watanabe K. Nato K. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Clin. Infect. Dis. 16 (Suppl. 4) 1993 S382 S386","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF01962077","article-title":"Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents.","volume":"11","author":"Betriu C.","year":"1992","unstructured":"Betriu C. Cabronero C. G\u00f3mez M. Picazo J. J. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 11 1992 352 356","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.9.2320"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jac\/43.5.703","article-title":"In vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests.","volume":"43","author":"Fuchs P. C.","year":"1999","unstructured":"Fuchs P. C. Barry A. L. Brown S. D. In vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests. J. Antimicrob. Chemother. 43 1999 703 706","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2389-2394.2000"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1830"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/AAC.43.5.1170","article-title":"In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum \u03b2-lactamase and extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.","volume":"43","author":"Kholer J.","year":"1999","unstructured":"Kholer J. Dorso K. L. Young K Hammond G. G. Rosen H. Kropp H. Silver L. L. In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum \u03b2-lactamase and extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates. Antimicrob. Agents Chemother. 43 1999 1170 1176","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.10.2517"},{"key":"e_1_3_1_12_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Methods for antimicrobial susceptibility testing of anaerobic bacteria 4th ed. Approved standard. NCCLS publication no. M11\u2013A4.\n          National Committee for Clinical Laboratory Standards Wayne Pa.\n          1997"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.10.2417"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2276"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2222-2224.2000"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.8.2372-2374.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.8.2372-2374.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:02:10Z","timestamp":1645462930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.45.8.2372-2374.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1128\/AAC.45.8.2372-2374.2001"],"URL":"https:\/\/doi.org\/10.1128\/aac.45.8.2372-2374.2001","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2001-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}